Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Molecular imaging of the dopamine transporter.

Varrone A, Halldin C.

J Nucl Med. 2010 Sep;51(9):1331-4. doi: 10.2967/jnumed.109.065656. Epub 2010 Aug 18. Review.

2.
3.

The dopamine transporter: role in neurotoxicity and human disease.

Bannon MJ.

Toxicol Appl Pharmacol. 2005 May 1;204(3):355-60. Review.

PMID:
15845424
4.

Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.

Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice R, Shults CW, Stoessl AJ.

Exp Neurol. 2003 Nov;184 Suppl 1:S68-79. Review.

PMID:
14597329
5.

ADHD and the dopamine transporter: are there reasons to pay attention?

Mazei-Robinson MS, Blakely RD.

Handb Exp Pharmacol. 2006;(175):373-415. Review.

PMID:
16722244
6.

The dopamine transporter and attention-deficit/hyperactivity disorder.

Madras BK, Miller GM, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1397-409. Epub 2005 Jan 5. Review.

PMID:
15950014
7.

Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.

Neuroscience. 2010 Jun 2;167(4):1183-91. doi: 10.1016/j.neuroscience.2010.02.073. Epub 2010 Mar 6.

PMID:
20211696
8.

Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations.

Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, Zarrabian D, Comings D, Sellers EM, Tyndale RF, George SR, O'Dowd BF, Uhl GR.

Mol Psychiatry. 2000 May;5(3):283-92.

PMID:
10889531
9.

Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer.

Gedeon PC, Indarte M, Surratt CK, Madura JD.

Proteins. 2010 Mar;78(4):797-811. doi: 10.1002/prot.22601.

PMID:
19899168
10.

Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.

Ba F, Martin WR.

Parkinsonism Relat Disord. 2015 Feb;21(2):87-94. doi: 10.1016/j.parkreldis.2014.11.007. Epub 2014 Nov 20. Review.

PMID:
25487733
11.

[The dopamine transporter: characterization and physiopathologic implications].

Thibaut F, Vaugeois JM, Petit M.

Encephale. 1995 Nov-Dec;21(6):445-51. Review. French.

PMID:
8674469
12.

Molecular imaging of dopamine transporters.

Brooks DJ.

Ageing Res Rev. 2016 Sep;30:114-21. doi: 10.1016/j.arr.2015.12.009. Epub 2016 Jan 21. Review.

PMID:
26802555
13.

Dopamine transporter haplotype and attention-deficit hyperactivity disorder.

Galili-Weisstub E, Levy S, Frisch A, Gross-Tsur V, Michaelovsky E, Kosov A, Meltzer A, Goltser T, Serretti A, Cusin C, Darvasi A, Inbar E, Weizman A, Segman RH.

Mol Psychiatry. 2005 Jul;10(7):617-8. No abstract available.

PMID:
15940306
14.

Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.

Sossi V, de la Fuente-Fernández R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ.

Ann Neurol. 2007 Nov;62(5):468-74.

PMID:
17886297
15.

Regulation of the dopamine transporter by phosphorylation.

Foster JD, Cervinski MA, Gorentla BK, Vaughan RA.

Handb Exp Pharmacol. 2006;(175):197-214. Review.

PMID:
16722237
16.

SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.

Krause J.

Expert Rev Neurother. 2008 Apr;8(4):611-25. doi: 10.1586/14737175.8.4.611. Review.

PMID:
18416663
17.

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Hansen FH, Skjørringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, Law I, Pinborg LH, Sitte HH, Loland C, Shi L, Weinstein H, Galli A, Hjermind LE, Møller LB, Gether U.

J Clin Invest. 2014 Jul;124(7):3107-20. doi: 10.1172/JCI73778. Epub 2014 Jun 9.

18.

Mechanisms of dopamine transporter regulation in normal and disease states.

Vaughan RA, Foster JD.

Trends Pharmacol Sci. 2013 Sep;34(9):489-96. doi: 10.1016/j.tips.2013.07.005. Epub 2013 Aug 20. Review.

19.

Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.

Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F.

EMBO J. 2007 Apr 18;26(8):2127-36. Epub 2007 Mar 22.

20.

Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter.

Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG.

CNS Neurol Disord Drug Targets. 2006 Feb;5(1):45-56. Review.

PMID:
16613553

Supplemental Content

Support Center